About this Research Topic
Cardiovascular disease (CVD) is the leading cause of death worldwide. Although significant progress has been made in the treatment of CVD, the burden of CVD continues to increase due to the high prevalence of cardiovascular risk factors such as obesity, dyslipidaemia, hypertension, and diabetes. In light of this, early diagnosis and novel effective therapies are important to reduce death and suffering caused by CVD.
Multi-omics offers a strategy for discovering novel biomarkers and improving clinical decision making for patient management. Such advanced strategies can not only provide useful information for early diagnosis, prognosis, and risk stratification of CVD, but has also greatly accelerated understanding the underlying pathophysiological mechanisms and developing new therapies for treating or preventing CVD. Natural multiple bioactive compounds or extract from traditional herbal medicines are emerging as novel and alternative medical agents with multitargeted cardioprotective effects. However, it is difficult for modern medical scientists to recognize and accept their practical values. Omics strategy is an important component of systems biology, with a research idea that is similar to the overall concept of traditional medicines. Therefore, the use of high-throughput omics techniques provide great opportunities for providing effective evidence for the action mechanisms of multicomponent-based cardioprotective agents, including traditional herbal medicines.
In this Research Topic, we invite researchers to submit novel research articles, state-of-the-art reviews, and communications related to the fields of novel omics technique-based biomarkers and alternative therapies in cardiovascular disease. Such papers can focus on the application of metabolomics, proteomics, genomics, micro-biomics, and multi-omics technologies in cardiovascular outcomes after intervention, the primary and secondary prevention of cardiovascular diseases, risk stratification, traditional herbal cardioprotective medicines and more. We look forward to receiving your contributions and to future collaborations.
Multi-omics offers a strategy for discovering novel biomarkers and improving clinical decision making for patient management. Such advanced strategies can not only provide useful information for early diagnosis, prognosis, and risk stratification of CVD, but has also greatly accelerated understanding the underlying pathophysiological mechanisms and developing new therapies for treating or preventing CVD. Natural multiple bioactive compounds or extract from traditional herbal medicines are emerging as novel and alternative medical agents with multitargeted cardioprotective effects. However, it is difficult for modern medical scientists to recognize and accept their practical values. Omics strategy is an important component of systems biology, with a research idea that is similar to the overall concept of traditional medicines. Therefore, the use of high-throughput omics techniques provide great opportunities for providing effective evidence for the action mechanisms of multicomponent-based cardioprotective agents, including traditional herbal medicines.
In this Research Topic, we invite researchers to submit novel research articles, state-of-the-art reviews, and communications related to the fields of novel omics technique-based biomarkers and alternative therapies in cardiovascular disease. Such papers can focus on the application of metabolomics, proteomics, genomics, micro-biomics, and multi-omics technologies in cardiovascular outcomes after intervention, the primary and secondary prevention of cardiovascular diseases, risk stratification, traditional herbal cardioprotective medicines and more. We look forward to receiving your contributions and to future collaborations.
Keywords: cardiovascular diseases, omics, system biology, biomarkers, metabolic diseases, molecular mechanism, traditional medicines
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
